Le Lézard
Classified in: Health
Subjects: CCA, FVT

PLANET FITNESS, INC. TO REPORT FOURTH QUARTER 2023 RESULTS ON FEBRUARY 22, 2024


HAMPTON, N.H., Feb. 8, 2024 /PRNewswire/ -- Planet Fitness, Inc. (NYSE: PLNT) (the "Company"), today announced that the Company will report results for its fourth quarter ended December 31, 2023, before the market opens on Thursday, February 22, 2024.

The Company will discuss its fourth quarter financial results on a conference call scheduled at 8:00 a.m. Eastern Time on the same day. A live webcast of the conference call will be available at http://investor.planetfitness.com. Investors may also obtain a dial-in number and passcode by following the pre-registration link: https://registrations.events/direct/Q4I10943

For those unable to participate in the live call, a digital recording will be available within two hours following the call and will remain available through midnight Thursday, February 29, 2024. To access the replay, please call 1-800-770-2030 (Toll-Free) or 1-609-800-9909 (Toll) and enter confirmation code 10943.

About Planet Fitness

Founded in 1992 in Dover, NH, Planet Fitness is one of the largest and fastest-growing franchisors and operators of fitness centers in the world by number of members and locations. As of December 31, 2023, Planet Fitness had approximately 18.7 million members and 2,575 stores in 50 states, the District of Columbia, Puerto Rico, Canada, Panama, Mexico and Australia. The Company's mission is to enhance people's lives by providing a high-quality fitness experience in a welcoming, non-intimidating environment, which we call the Judgement Free Zone®. More than 90% of Planet Fitness stores are owned and operated by independent businessmen and women.

Planet Fitness (PRNewsfoto/Planet Fitness, Inc.)

SOURCE Planet Fitness, Inc.


These press releases may also interest you

at 04:19
Medivir to present data for the combination of fostrox + Lenvima in HCC at ESMO GI
Medivir AB (STO: MVIR), a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need, announced today that an abstract for the combination of fostroxacitabine bralpamide (fostrox) + Lenvima® in...

at 04:15
Asimov Achieves 10x Improvement in Lentiviral Production, Launches New Stable Cell Line Development Service
Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the expansion of its LV Edge System with the launch of a fully stable cell line development service. There are now two ways for customers to...

at 04:07
Huma and Merck KGaA, Darmstadt, Germany Launch Innovative App to Support Bladder Cancer Patients
Huma Therapeutics ("Huma"), a leader in global digital health innovation, together with Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced the launch of their innovative bladder cancer treatment companion app in...

at 04:00
Calibre Scientific Acquires Camlab Limited, a UK Provider of Scientific Equipment, Chemicals, Consumables and Other Laboratory Supplies
Calibre Scientific is pleased to announce the acquisition of Camlab Limited ("Camlab" or the "Company"), a UK-based supplier of scientific equipment, chemicals, consumables, labware, and other laboratory supplies and services to customers in the...

at 04:00
Hurom Takes Global Action to Protect Juicer Patents
Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its proprietary technology and contribute to a healthy industry ecosystem. Despite...

at 03:46
Biosimilar Testing and Development Services Market to Hold $7.8 Billion, by 2032 with 12.1% CAGR: Allied Market Research
Allied Market Research published a report titled, "Biosimilar Testing and Development Services Market Share, Size, Competitive Landscape and Trend Analysis Report by Type, by End User: Global Opportunity Analysis and...

More news about Health...


News published on and distributed by: